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Geminin Is Required for Epithelial to Mesenchymal
Transition at Gastrulation
Lisa S.D. Emmett and K. Sue O’Shea
Geminin is a multifunctional protein previously suggested to both maintain the bone morphogenetic protein
inhibition required for neural induction and to control cell-cycle progression and cell fate in the early embryo.
Since Geminin is required in the blastocyst on E3.5, we employed shRNA to examine its role during post-
implantation development. Geminin knockdown inhibited the epithelial to mesenchymal transition (EMT) re-
quired at gastrulation and neural crest delamination, resulting in anterior-posterior axis and patterning defects,
while overexpression promoted EMT at both locations. Geminin was negatively correlated with expression of
E-cadherin, which is critically involved in controlling epithelial architecture. In addition, Geminin expression
level was correlated with Wnt signaling and expression of the Wnt target gene Axin2 and with Msx2, and
negatively correlated with the expression of Bmp4 and Neurog1 in quantitative reverse transcriptase–polymerase
chain reaction analysis of RNAs from individual embryos. These results suggest that in addition to patterning
the early embryo, Geminin plays a previously unrecognized role in EMT via its ability to affect Wnt signaling
and E-cadherin expression.
Introduction
The epiblast is patterned by reciprocal signaling be-tween embryonic and extra-embryonic tissues to first
position the proximal-distal (PD) axis; the anterior migration
of the distal visceral endoderm then breaks the radial sym-
metry of the embryo and establishes the anterior-posterior
(AP) axis [1,2]. At the onset of gastrulation, cells at the pos-
terior pole of the epiblast divide and move medially in the
primitive streak [3]. Subsequent epithelial to mesenchymal
transition (EMT) and formation of the 3 definitive germ layers
depend on the convergence of multiple signal transduction
pathways to downregulate E-cadherin [4], and control the
ensuing expression of genes involved in cell migration and in
lineage differentiation. The ectoderm is then patterned by
controlled bone morphogenetic protein (BMP) signaling [5],
although additional molecules are likely required in the
mammalian embryo [6].
One candidate previously identified, based on its ability to
affect the size of the Xenopus neural plate [7], is the 33 kDa
protein Geminin. Geminin has been suggested to act as a
switch between proliferation and differentiation of many
tissues [8–10] and certain cancers [11,12] presumably via its
ability to control cell-cycle progression by associating with
Cdt1 [13]. Despite its provocative function in Xenopus em-
bryos, the role of Geminin during early mammalian devel-
opment is largely unknown since deletion is lethal on E3.5 of
development [14,15] due to over-replication of DNA.
In the postimplantation embryo, Geminin is expressed
initially in the epiblast at E6.5; with neural induction and
gastrulation, Geminin is present in the neural plate and
primitive streak, while extra-embryonic tissues and the epi-
dermal ectoderm consistently lack Geminin. To examine its
role in development, we overexpressed a Geminin cDNA or
employed shRNAs to knockdown Geminin expression. As
Geminin expression decreased, Wnt signaling and Bmp4 ex-
pression were attenuated, while overexpression expanded
both. Geminin shRNA embryos also failed to initiate Fgf8 ex-
pression in the primitive streak and E-cadherin was strikingly
upregulated, abrogating EMT and gastrulation movements.
Cell migration through the node and primitive streak was
affected, inhibiting AP axis elongation and producing defects
of neural tube and body wall closure. Conversely, over-
expression attenuated E-cadherin expression, promoting pre-
mature EMT at both the primitive streak and neural crest.
These results identify a novel role for Geminin in EMT and
highlight the central role of this transition in development,
metastasis, and recently, in cellular reprogramming.
Materials and Methods
Mice
Time-pregnant ICR strain (Harlan) or ‘‘Wnt indicator’’
mice expressing b-galactosidase via 6 transcription factor/
lymphoid enhancer binding factor (TCF/LEF) sites [16] were
employed and embryos harvested on E6.5–E17.0. To monitor
Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.
STEM CELLS AND DEVELOPMENT
Volume 21, Number 13, 2012
 Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2011.0483
2395
the health status of pregnant dams after shRNA exposure,
blood chemistries were analyzed by Unit for Laboratory
Animal Medicine (ULAM) Pathology Core and did not
identify significant variations in health profile. All protocols
were reviewed and approved by the University of Michigan
Committee on the Use and Care of Animals.
DNA delivery
E6.0 time-pregnant mice were injected via the tail-vein with
5mg each of 2 shRNAs targeting Geminin or scrambled hairpin
control shRNA constructs (Supplementary Fig. S1; Supple-
mentary Data are available online at www.liebertonline
.com/scd) in 150mL Ringer’s solution as previously described
[17]. For overexpression, the US2 promoter drove a Geminin
cDNA and enhanced green fluorescent protein (EGFP).
shRNA targeting Geminin or scrambled control shRNA was
also injected into the pronucleus of fertilized zygotes, (C57BL/
6 · SJL)F2 by the University of Michigan Transgenic Animal
Core. Embryos were transferred to pseudopregnant dams and
allowed to develop to E6.5–E9.5.
Tissue analysis
Mice were sacrificed, embryos dissected from amnion and
chorion, and digital images obtained prior to fixation. For
whole-mount immunohistochemistry and whole-mount
in situ hybridization (WISH), embryos were fixed for 10 min
in 2% PFA. Embryos for WISH were dehydrated in MeOH,
then stored at - 20C. For SEM, embryos were fixed in 1%
glutaraldehyde, dehydrated, followed by hexamethyldisila-
zane, and then examined in an Amray 1910 SEM. Individual
embryos for quantitative reverse transcriptase–polymerase
chain reaction (qRT-PCR) were placed in Trizol (ILT), and
those for western blot analysis were placed in RIPA/
7 · complete buffer (Roche) and stored at - 20C.
Quantitative RT-PCR
RNAs were extracted using Trizol. To minimize variation,
control embryos were carefully staged: Stage 1: primitive
streak (E7.0) to 4–5 somites; Stage 2: 5–10 somites; Stage 3:
10–12 somites; Stage 4: 12–25 somites. RNAs were also col-
lected from blastocyst, E11, E13, E15, and E17 staged em-
bryos, from individual Stage 3 and Stage 4 embryos exposed
to Geminin shRNA (n = 7 and n = 30), scrambled shRNA
(n = 10 and n = 22), or to the Geminin cDNA (Stage 4, n = 36)
and reverse transcribed using 1 mg RNA and random non-
amers. qRT-PCR was performed in triplicate using iQ SYBR
green supermix (BioRad) with b-actin as a reference. Primer
sequences are provided in Supplementary Table S1. Mean
control Ct values were used as the reference for embryos
exposed to Geminin shRNA or cDNAs, and fold changes
calculated [18].
Western blotting
Individual E9.0 embryos were homogenized, protein
quantified using the Bradford reagent (BioRad), subjected to
polyacrylamide gel electrophoresis, and exposed to Geminin
(1:1000; Santa Cruz sc-13015), b-actin (1:20,000; Sigma
#A1978), and E-cadherin (1: 200; Cell Signaling) antibodies.
Exposure to rabbit anti-HRP (1:2000) and mouse anti-HRP
(1:20,000; Jackson Immunoresearch) was followed by detec-
tion in luminol (Supersignal West pico chemiluminescent
substrate, Thermo Scientific) and exposure to film for 1 min.
Band intensity was determined using a BioRad ChemiDoc.
Statistical analysis
Expression data were analyzed using Student’s t-test, with
linear regression analyses of western blot and qRT-PCR data
using SPSS.
Immunohistochemistry
Embryos were exposed to primary antibody overnight at 4C
followed by appropriate secondary antibodies. Primary anti-
bodies were: Foxa2 (1:1000; Millipore #07-633), Sox3 (1:2000 ;
MW Klymkowsky, Denver, CO), E-cadherin (1:500; BD #610181
and S Weiss, University of Michigan), laminin (1:25; Sigma
#L9393), TuJ1 (1:200; Covance #MMS-435P), phospho-histone
H3 (1:2000; Upstate #09-797), DsRed (1:100; SantaCruz,
#SC33353), and EGFP (1:500; Abcam #42560). Secondary anti-
bodies were conjugated to Alexa-488 (1:1000), Texas Red
(1:500), FITC (1:500), or HRP (1:200) ( Jackson Immunoresearch
Laboratories). Hoechst 33258 (1mM) was used to identify nuclei.
X-gal staining was carried out (www.sanger.ac.uk/genetrap/)
with 20mg/mL X-gal (ILT #15520-034). TUNEL staining was
carried out following the manufacturer’s protocol (Promega).
Images were captured using an Olympus BX-51, Leica dis-
secting scope, Leitz Fluovert, and/or a Zeiss 541 confocal mi-
croscope and transferred to Photoshop to assemble plates.
Whole-mount in situ hybridization
Embryos were treated with proteinase K, and WISH was
carried out [19]. Probes were generated using T3 or T7
polymerase and DIG-11-UTP labeling kit (Roche). A 412 bp-
Geminin probe was generated by linearizing pSK using BsAI
and transcribing with T3 polymerase (NM_020567 nt 564 to
976). The 751 bp-Brachyury probe was first linearized from
pSK by Xho 1 and transcribed using T3 (NM_009309 nt 476
to 1227). Additional probes used were obtained from Bmp4
[20], Cer1 [21], Engrailed-2 [22], Hesx1 [23], Shh [24], Fgf8 [25],
Msx2 [26], Snail1 [4], and Nodal [27]. Detection was carried
out using anti-DIG-AP and NBT/BCIP (Roche). After pho-
tography as whole mounts, 10 micron frozen sections were
cut and photographed.
Results
Geminin expression is initially restricted to the
epiblast, primitive streak, and neural ectoderm
Geminin mRNA was present in the epiblast and forming
neural ectoderm (Fig. 1A–C), expression terminating sharply
at its boundary with the epidermal ectoderm (Fig. 1B, C ar-
row). It was expressed in the primitive streak (Fig. 1A, C) and
dorsal node (Fig. 1A, B arrowheads) on E7.5, but was not
present in extra-embryonic tissues at any stage examined (Fig. 1).
By E8.5 and E9.5, Geminin was expressed throughout the
neural ectoderm (Fig. 1D–I, E double arrows), but continued to
be excluded from the epidermal ectoderm (Fig. 1D–F, I ar-
rows), from the endoderm, and the heart. Overall, mRNA
expression peaked at 5–10 somites, declining until E13 then
increasing during organogenesis (Supplementary Fig. S3A).
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FIG. 1. Geminin expression.
Whole-mount in situ hybrid-
ization localization of Geminin
mRNA in control embryos on
E7.5 (A–C), E8.5 (D–F), and
E9.5 (G–I); in E8.5 Geminin
shRNA embryos ( J–L) and
E8.5 Geminin overexpressing
embryos (M–O). A, allantois;
H, heart; Hf, headfolds;
NE, neural ectoderm; ntc, no-
tochord; ov, otic vesicle; pnp,
posterior neuropore; PS,
primitive streak; arrowhead in
A, B, node; arrow in B, C, D, E,
F, I, N, epidermal ectoderm;
dashed line in B, edge of epi-
dermal ectoderm; double ar-
rows in E, Geminin expression
in the neural tube. Anterior is
to the left in: A, D, G, J, M.
Anterior (coronal) views: B, E.
Dorsal views: F, H, K, N.
Transverse sections with an-
terior at top: C, I, L, O. Scale
bars = 200 mm except (C, L, O)
which are 100 mm. Color ima-
ges available online at www
.liebertonline.com/scd
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Geminin expression can be modified by exposure
to Geminin shRNA or a Geminin cDNA
shRNA to knockdown or a Geminin cDNA to overexpress
Geminin were delivered to pregnant dams on E6.0 [28,29].
Additional embryos were injected at the pronuclear stage
with either an shRNA or a scrambled control shRNA (Sup-
plementary Fig. S1). Little mRNA was detected in shRNA
embryos (Fig. 1J–L), while exposure to the Geminin cDNA
(Fig. 1M–O) increased Geminin mRNA in the neural ecto-
derm, but not heart or epidermal ectoderm (Fig. 1N arrow),
possibly regulated by the many microRNAs that may target
Geminin. Immunohistochemical localization of DsRed or
EGFP indicated that the plasmids were widely expressed in
postimplantation embryos, with considerable overlap with
Hoechst 33258 (Supplementary Fig. S2).
shRNA exposure significantly reduced Geminin mRNA
expression ( > 6-fold, P < 0.001) compared with scrambled
shRNA embryos, while the Geminin cDNA increased ex-
pression by 6.2-fold (P < 0.001; Supplementary Fig. S3B).
Geminin protein was 134.1% of control expression after
cDNA exposure and 54.4% of control levels (P < 0.001) after
shRNA-treatment (Supplementary Fig. S3C and Table 1);
individual embryos exhibited a range in Geminin protein
from control levels to virtually no protein (Supplementary
Fig. S3D). This technique can produce graded knockdown
similar to electroporation or to an allelic series with a cor-
responding range of phenotypes within a litter (Supple-
mentary Fig. S4).
Geminin is required during preimplantation
development
Pronuclear injection of shRNA produced significant pre-
implantation loss with surviving embryos (18%) often ex-
hibiting few anomalies (Supplementary Fig. S1G–I). However,
by delivering the shRNAs on E6.0 to bypass the early re-
quirement for Geminin, we were able to obtain knockdown in
more than 70% of the embryos.
Geminin is required in the epiblast for axis
elongation and neurulation
By E7.5, control embryos had well-organized neural folds
and an expanded amniotic cavity as a result of normal axis
elongation (Supplementary Fig. S1A). In Geminin shRNA-
exposed embryos (Supplementary Fig. S1D), the node was
positioned anteriorly and AP axis elongation was inhibited,
like the rare surviving embryos after pronuclear injection of
shRNA (Supplementary Fig. S1G). Geminin overexpression
was often lethal; surviving embryos (Supplementary Fig. S1J)
were often composed of headfolds and membranes with
disorganized posterior tissues.
By E8.5, compared with control embryos (Supplementary
Fig. S1B), the anterior- and posterior neuropores of shRNA
embryos remained widely open (Supplementary Fig. S1E, H).
Overexpression of Geminin resulted in posterior disorgani-
zation with relatively well-formed headfolds (Supplemen-
tary Fig. S1K). When E9.0 embryos were examined using
SEM, the anterior neural folds of controls were approaching
the dorsal midline (Supplementary Fig. S5A, D, G) compared
with shRNA- and cDNA-exposed embryos, where the neural
folds were widely everted (Supplementary Fig. S5B, C, E, F,
H, I) and massively overgrown in overexpressing embryos
(Supplementary Fig. S5C, F, I). The proepicardium, which
also undergoes EMT, failed to cover the heart tube of shRNA
embryos (Supplementary Fig. S5H). By E9.5, the anterior
neural tube had closed in control embryos (Supplementary
Fig. S1C), while shRNA embryos often had open, everted
neural folds (Supplementary Fig. S1F arrows). The first
branchial arch was also small and abnormally oriented.
Surviving embryos carrying the hairpin shRNA express
DsRed or EGFP (Supplementary Figs. S1F, I, S2D, G). Em-
bryos that survived Geminin overexpression to E9.5 often
failed to undergo the normal turning process and the neural
ectoderm was overgrown (Supplementary Fig. S1L arrows).
Geminin is required for morphogenetic cell
movements at gastrulation
At gastrulation, cells delaminate from the primitive streak
to form endoderm by intercalating and replacing the primi-
tive endoderm (PE) with definitive (embryonic) endoderm
(DE) [30]. As gastrulation proceeds, the boundary between
the PE and DE progresses from distal to proximal, termi-
nating at the extra-embryonic margin (Fig. 2A, C asterisks;
2C dashed line in inset). In Geminin shRNA embryos, this
boundary failed to migrate (Fig. 2B, D asterisks) suggesting
that DE does not replace PE. PE markers including HRP,
illustrate a similar lack of cell movement (not shown) indi-
cating that Geminin is required for differentiation or migra-
tion of the DE.
Compared with control embryos (Fig. 2A, C, E), both the
foregut and hindgut pockets were widely open in shRNA
embryos (Fig. 2B, D, F), likely due to the lack of elongation
and morphogenetic movements required for body wall clo-
sure. Foxa2 was expressed in the DE that lines the node and
foregut pocket (Fig. 2E, F), highlighting the widely open
foregut pocket, shortened anterior-posterior axis, and ab-
normal headfold positioning in shRNA embryos (Fig. 2F).
Table 1. Regression Analysis
Group E-cadherin Geminin Ratio R2 f P < T
Pooled embryos 1.3 0.001 0.77 0.00001 5.48
Missense 99.8 + 7.7 100.2 + 12.6 0.99 0.275 0.02 0.0009 4.8
shRNA 202.3 + 26.8 54.4 + 4.7 3.72 0.776 0.00 0.021 - 2.4
OE 65.2 + 5.6 134.1 + 15.0 0.49 0.15 0.02 0.00008 4.74
E-cadherin expression is inversely correlated with Geminin protein levels. Regression analysis of individual embryos after knockdown or
overexpression of Geminin in comparison to E-caderin expression.
OE, overexpressing.
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Loss of Geminin affects cell migration through
the node
Normally, the node has a slightly concave appearance
(Fig. 2A, E, G); cells at the tip involute as the AP axis
elongates and the node moves posteriorly [31]. When Ge-
minin expression was downregulated, the node failed to
regress, forming a deep, concave pit (Fig. 2B, H white ar-
rowheads), leaving a cluster of unorganized cells behind
(Fig. 2H black arrowheads). However, Nodal expression in
the surrounding crown cells was not affected by Geminin
dosage (not shown).
Geminin is required for EMT at gastrulation
The primitive streak is a pseudostratified epithelium from
which mesendoderm cells delaminate at the midline (Fig. 3A
arrowhead). In shRNA embryos, cells fail to leave the
primitive streak resulting in an overgrown epiblast (Fig. 3E
white arrow), while Geminin overexpression resulted in
premature EMT and disorganization of the posterior pole of
the embryo (Fig. 3I). In control embryos, E-cadherin ex-
pression decreased at the midline (Fig. 3B, arrowhead);
however, in Geminin shRNA embryos E-cadherin persisted
in the primitive streak, mesoderm, and endoderm (Fig. 3F
arrowhead). In overexpressing embryos, there was less
E-cadherin in the epithelium and the newly formed me-
sendoderm, whereas it remained at high levels in the PE
(Fig. 3J arrows). Laminin, which is expressed in the basement
membrane of the ectoderm except the midline of the primi-
tive streak where cells ingress, was also affected by Geminin
dose. When Geminin was overexpressed, the normally linear
pattern of laminin immunoreactivity was irregular and
punctate, while in knockdown embryos it remained in the
basement membrane throughout its extent. In immunoblots
of protein from individual embryos, Geminin protein was
strongly negatively correlated with E-cadherin levels (Fig.
3M, N; discussion below).
X-gal staining of control ‘‘Wnt indicator’’ embryos [16]
indicated that Wnt signaling was normally tightly restricted
to the primitive streak (Fig. 3C, D). However, in Geminin
shRNA embryos, signaling was reduced (Fig. 3G, H), while
overexpression expanded the Wnt-signaling domain into the
mesoderm (Fig. 3K, L). The early expression of Bmp4 in the
extra-embryonic ectoderm and epidermal ectoderm of con-
trol embryos (Fig. 4A) was expanded in shRNA embryos,
(Fig. 4G), suggesting that Bmp4 (and Nodal) are expressed at
sufficient levels to position the node, but Geminin is required
to constrain the Bmp4 expression domain as in Xenopus [7].
In control embryos, Cer1 and Hesx1 were expressed in the
anterior endoderm (Fig. 4B, C); Geminin knockdown ex-
panded their expression domains posteriorly (Fig. 4H, I).
Fgf8 and Snail1 were present in the primitive streak of control
embryos (Fig. 4D, E); but they were down regulated in
Geminin shRNA embryos (Fig. 4J, K). Brachyury, present in
early mesoderm of the primitive streak and node (Fig. 4F),
had a slightly wider expression domain near the allantois of
shRNA embryos (Fig. 4L). In transverse section, Brachyury is
expressed in the primitive streak and newly forming meso-
derm in missense control embryos (Fig. 7J), compared with
shRNA embryos, where there is little mesoderm and strong
ectodermal expression (Fig. 7N).
FIG. 2. Alterations at the node. E7.5 embryos exposed to
scrambled shRNA (A, C, E, G) or to Geminin shRNA (B, D, F,
H) were analyzed using SEM or Foxa2 expression in sagittal
sections (E, F). Arrowheads (A–F), node; *(A–D), border of PE
and DE; white arrowhead (G, H), ciliated cells of the node;
black arrowheads (H), aggregate of cells at the node; f, foregut
pocket; Hf, headfolds; PS, primitive streak. Anterior view in
A, B; Anterior is to the left in C–F; Distal tip of the embryo
toward the top in G, H (inset is posterior to anterior orien-
tation). Scale bars = 100mm (A–D, G, H), 10 mM (inset in C),
and 200 mm (E, F). PE, primitive endoderm; DE, definitive
endoderm. Color images available online at www
.liebertonline.com/scd
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FIG. 3. Organization of the primitive streak. The primitive streak of control embryos (A–D), Geminin shRNA embryos
(E–H), and Geminin overexpressing embryos (I–L) was analyzed using SEM of transverse fractures (A, E, I), E-cadherin
localization in transverse sections (B, F, J), and b-gal expression in ‘‘Wnt-indicator’’ mice (C, D, G, H, K, L). Anterior is to the
left in C, G, K. D, H, L are transverse sections at levels indicated in C, G, and K with anterior at top. A, allantois; E, ectoderm;
En, endoderm; M, mesoderm; PS, primitive streak; arrowhead (A–B, E–F, I–J), primitive streak; arrowhead (C, G, K), node;
white arrow (E), overgrown epiblast. Scale bars = 100 mm (A, B, E, F, I, J), 200mm (C, D, G, H, K, L). M. Western blot analysis of
the relative expression of E-cadherin in scrambled shRNA control, Geminin shRNA-exposed embryos and embryos over
expressing (OE) Geminin. E-cadherin expression is inversely related to Geminin. *P < 2.1 · 10 - 8, **P < 0.02, ***P < 2.6 · 10 - 14,
Students t-tests. N. Representative western blots illustrating E-cadherin, Geminin, and b-actin in individual E9.0 embryos
exposed to scrambled (lane 1), Geminin shRNA (lane 2), or Geminin overexpression (OE; lane 3) constructs. Color images
available online at www.liebertonline.com/scd
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Geminin dose controls neural crest EMT
Combinatorial signaling by Wnts, BMPs, and fibroblast
growth factors (FGFs) is thought to specify the neural crest
[32]. In control embryos, Snail1 and Msx2 were expressed at
the margins of the neural folds and by neural crest cells (NCC)
migrating into the mesenchyme (Fig. 5A, J) in both the ce-
phalic region (Fig. 5D, M) and the posterior neuropore (Fig.
5G, P). Msx2 was also expressed in the lateral plate mesoderm
that will line the body wall and gut tube (Fig. 5M, P), and
Snail1 in the extra-embryonic mesoderm of the allantois (not
shown). In Geminin shRNA embryos, expression of both genes
was strikingly downregulated in the anterior neural crest and
mesenchyme (Fig. 5B, E, K, N arrow), although some Snail1
was present in NCC in the branchial arches (Fig. 5E arrow).
The posterior neuropore was often flattened and there was
little Snail1 expressed in this region (Fig. 5H), or in the allan-
tois (not shown). Msx2 was similarly strongly downregulated
in the posterior region although there was ectopic expression
of Msx2 in the aggregate of cells at the junction of the posterior
neuropore with the primitive streak (Fig. 5Q arrowheads).
Overexpression of Geminin increased Snail1 (Fig. 5C, F) and
Msx2 (Fig. 5L, O) in NCC. Both were strongly expressed in the
mesenchyme of the headfolds and branchial arches (Fig. 5F, O
arrows), the posterior neuropore (Fig. 5I, R arrows), and al-
lantois (not shown). Geminin dose did not produce alterations
in either proliferation or cell death (not shown), however.
E-cadherin expression is negatively correlated
with Geminin level
Given the striking changes in E-cadherin expression in the
embryo in immunohistochemistry, and the central role of
E-cadherin in controlling EMT, we quantified E-cadherin
protein from individual embryos using western blot. Gemi-
nin expression level was normalized to b-actin to control
loading, then compared to E-cadherin. Geminin was ex-
pressed at highest levels in single overexpressing embryos
and significantly decreased in shRNA-treated embryos (Ta-
ble 1). E-cadherin was reciprocally expressed; E-cadherin
was high in shRNA-exposed embryos and significantly de-
creased when Geminin levels were increased. We examined
the relationship between E-cadherin and Geminin first using
ratios (Table 1 and Fig. 3M, N); the means were significantly
different between the groups when analyzed using t-test.
Data were also analyzed using regression analysis. When
data from all embryos were pooled, there was a consistent
significant correlation in Geminin expression level and the
expression of E-cadherin (P £ 0.00001, t = 5.479). Within treat-
ment groups, the correlations were positive, except in the
shRNA embryos where high E-cadherin was associated with
low levels of Geminin expression.
Wnt signaling is responsive to Geminin dosage
On E9.5, Wnt signaling was active in the dorsal rhomben-
cephalon, midbrain, and forebrain (Fig. 6A, D, G), in NCC mi-
grating to the first branchial arch, differentiating somites, and
posterior neuropore (Fig. 6A arrowhead). Geminin shRNA de-
creased b-gal expression throughout the embryo (Fig. 6B), but
particularly in migrating NCC, in the forebrain and midbrain
(Fig. 6B, E, H), the forming proepicardium (Fig. 6B, asterisk),
and posterior neuropore (Fig. 6B arrowhead). Overexpression
strikingly elevated signaling throughout the neuraxis, particu-
larly in the first arch, the midbrain, and the hindbrain (Fig. 6C,
F, I) and in somites and the posterior neuropore (Fig. 6C, F).
Anterior and posterior patterning is affected
by Geminin knockdown
In control embryos, Shh is expressed in the node and no-
tochord from the posterior pole of the embryo to the com-
missural plate (Fig. 7A–C). In shRNA embryos, there was
patchy expression of Shh in the notochord, (Fig. 7E, F) pro-
ducing a widened floor plate and neural tube closure ab-
normalities (Fig. 7F, G, M, O). Unlike controls (Fig. 7D), Shh
was not expressed in the liver bud of shRNA embryos (Fig.
7H), which would affect later differentiation of both the liver
and gall bladder.
By E9.5, the posterior neuropore (pnp) was closing (Fig. 7I)
and Brachyury expression was restricted to this region (Fig.
7J, J¢). In contrast, the pnp was consistently widely-open in
shRNA embryos (Fig. 7M) and Brachyury expanded into the
dorsal wall of the hindgut (Fig. 7N, N¢). There was decreased
FIG. 4. Geminin is required to pattern the embryo on E7.5. Whole-mount in situ hybridization was used to analyze gene
expression in E7.5 control (A–F) and Geminin shRNA (G–L) embryos. Embryos were hybridized with probes to: Bmp4 (A, G),
Cer1 (B, H), Hesx1 (C, I), Fgf8 (D, J), Snail1 (E, K), and Brachyury (F, L). Anterior is oriented to the left in all images except
(F, L), which are posterior (ventral) views. A, allantois; Hf, headfolds; PS, primitive streak; arrowhead, node. Scale bars =
200mm for all embryos. Color images available online at www.liebertonline.com/scd
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FIG. 5. Geminin dose con-
trols expression of Snail1 and
Msx2. Localization at E8.5 of
Snail1 (A–I) and Msx2 (J–R) in
control (A, D, G, J, M, P), Ge-
minin shRNA (B, E, H, K, N,
Q) and overexpressing em-
bryos (C, F, I, L, O, R) in
transverse sections of the an-
terior neural folds (D–F, M–
O), or posterior neuropore (G–
I, P–R). A, allantois; cp, com-
missural plate; H, heart; Hf,
headfolds; pnp, posterior neu-
ropore. Arrows indicate NCC
in D–I, M–O. In P–R arrow-
heads identify clusters of cells
at the junction of the pnp and
primitive streak. White arrows
indicate ectopic Msx2 expres-
sion. Anterior is to the left in:
A–C, J–L. Anterior toward the
top in: D–I, M–R. Scale bars =
200 mm (A–C, J–L); 100 mm
(D–I, M–R). Color images
available online at www
.liebertonline.com/scd
2402 EMMETT AND O’SHEA
Fgf8 expression in the wide ventral commissural plate, and in
the first branchial arch of Geminin shRNA embryos (Fig. 7O,
O¢, P arrows) compared with controls (Fig. 7K, K¢, L). This
was specific to the anterior neural folds as Fgf8 expression in
the isthmus and limb bud was unaffected by Geminin
knockdown. Engrailed-2, which is normally present in the
posterior midbrain and in rhombomere 1 of the hindbrain was
strikingly reduced in the midbrain but not in rhombomere 1
of shRNA embryos (not shown).
Geminin alters differentiation of neural
precursor cells
Prior research suggested that Geminin controls the switch
between proliferation of neural precursors and differentia-
tion into immature neurons [33,34]. In control embryos, Sox3
identifies proliferative neural precursors (Fig. 8A–C), while
TuJ1 appears later in midbrain neurons (Fig. 8J–L). In shRNA
embryos, Sox3 was reduced (Fig. 8D–F) and TuJ1 prema-
turely expressed throughout the neuraxis (Fig. 8M–O).
Overexpression of Geminin also decreased Sox3 (Fig. 8G–I),
while TuJ1 expression was increased (Fig. 8P–R). These re-
sults suggest that Geminin exerts stage-specific and context-
dependent control of ectoderm differentiation.
Gene expression analysis
To correlate Geminin and target gene expression, we carried
out qRT-PCR analysis of RNAs from individual embryos ex-
posed to shRNAs (Supplementary Table S2) and from single
embryos overexpressing Geminin (Supplementary Table S3),
followed by Pearson correlation. Geminin levels were posi-
tively correlated with the expression of the Wnt target
Axin2, and negatively correlated with Bmp4 and Neurog1 in
shRNA embryos. Brachyury expression was also negatively
correlated with Geminin, but did not reach statistical sig-
nificance. Interestingly, Foxa2 was correlated with both
Sox3 and Neurog1, likely reflecting overall embryonic de-
velopment. Axin2 and Neurog1 expression were also highly
correlated, markers of mesoderm (Brachyury) and neurons
(Neurog1) were negatively correlated, as were Bmp4 and
Sox3 expression (Supplementary Table S2). Like our in situ
results, Msx2 and Geminin were strongly correlated in
overexpressing embryos. Bmp4 was again strongly, nega-
tively correlated with Sox3 expression while Neurog1 was
positively correlated with Snail1 and Axin2 levels (Supple-
mentary Table S3). These results are consistent with the
observed increase in Snail1 expression in the embryo and
the strong stimulation of Wnt signaling in these embryos.
Overall, the most consistent effects were the strong negative
correlation between Geminin levels with Bmp4 and positive
correlation with Axin2, and the negative correlation be-
tween Bmp4 and Sox3.
Discussion
Despite its provocative prediction of the neural plate in
other species [7,10,35], this is the first investigation to examine
FIG. 6. Geminin dose affects
Wnt signaling. Embryos were
exposed to scrambled (A, D,
G), Geminin shRNA (B, E, H),
or Geminin overexpression (C,
F, I) constructs followed by
X-gal staining to identify sites
of Wnt signaling. (A–C) Sa-
gittal views of E9.5 embryos
with anterior to the left. (D–F)
Dorsal views. (G–I) Coronal
sections through the midbrain.
*Proepicardium; 1, first bran-
chial arch; H, heart; Hf, head-
folds; arrowhead, posterior
neuropore. Scale bars = 200 mm
(A–F), 100 mm (G–I). Color
images available online at
www.liebertonline.com/scd
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the expression and role of Geminin in the early post-
implantation-staged mouse embryo. Geminin was originally
described as a bi-functional molecule; the N-terminus impli-
cated in neural-cell fate determination [7], the C-terminus and
central regions involved in DNA replication and cell cycle
progression [13] in the Xenopus embryo. Geminin also binds
polycomb and Brahma proteins to regulate gene expression
[33,9]; it binds Hox and Six proteins to influence patterning of
the embryo [8,9,36]; our in vitro results (Slawny and O’Shea
this issue) suggest that it also binds nuclear TLEs to control the
Wnt-signaling cascade. Ultimately, competition for partner
proteins in a position- or stage-restricted manner may place
Geminin in a unique position to influence the differentiation
of many tissues.
FIG. 7. Geminin shRNA embryos are mispatterned along the length of the neuraxis. Whole-mount in situ hybridization was
used to analyze the expression of Shh (A–H), Brachyury ( J, N), and Fgf8 (K, L, O, P) with SEM employed for high-magnification
views of the posterior neuropore (I, M) in control (A–D, I–L) and Geminin shRNA-exposed embryos (E–H, M–P). Sagittal
views, with anterior to the left, include: (A–C, E–G, J, L, N, P), (K, O) are coronal (ventral) views, (I, M) are dorsal views of the
closing posterior neuropore, ( J¢, K¢, N¢, O¢) are transverse sections (section level indicated by * in J, K, N, O), and (D, H) are
sagittal sections through the heart and liver bud of E9.0 embryos. A, allantois; a, aorta; cp, commissural plate; g, gut; H, heart;
Hf, headfold; i (L, P), isthmus; Lv, liver bud; pnp, posterior neuropore; 1, first branchial arch; black arrowhead (A, E), node; black
arrowheads (F, G), misexpression of Shh; white arrowhead (C, D), Shh expression in the liver bud; black arrows (P), loss of Fgf8 in
the commissural plate and branchial arch; white arrows (B, C, F, G), Shh expression in the cranial region. Scale bars = 200mm (A–
C, E–G, J–L, N–P), 100mm (D, H, I, J¢, K¢, M, N¢, O¢). Color images available online at www.liebertonline.com/scd
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Geminin dosage controls EMT
The conversion of cells within an epithelial sheet to mes-
enchyme is essential in transforming the early egg cylinder
into the 3-germ layer embryo at gastrulation and is reiterated
and reversed multiple times during development [37,38].
EMT involves a series of well-characterized alterations in
cell-cell adhesion, cell polarity, expression of integrin recep-
tors, and cell migration [39]. Interestingly, the opposite
process—mesenchymal to epithelial transition—also appears
to be essential in reprogramming fibroblasts to epithelial
induced pluripotent cells [40,41].
Gene targeting has established that members of the Wnt,
Fgf, and transforming growth factor b superfamilies are es-
sential for EMT at gastrulation [37]. Lacking Geminin, em-
bryos fail to express Fgf8 in the primitive streak, thereby
affecting the cascade of Msx2, Msx1, and E-cadherin ex-
pression. E-cadherin is critically involved in maintaining the
integrity of the epithelial sheet; downregulation is required
for EMT and metastasis [38]. Our data demonstrate that at
the level of the individual embryo the amount of Geminin
present inversely correlates with the expression of E-cadherin.
The posterior disorganization observed with Geminin
overexpression is reminiscent of embryos where Wnt path-
way members are overexpressed, resulting in premature
EMT of the epiblast [42]. The Geminin gastrulation pheno-
type in KD embryos is also similar to mouse embryos lacking
Hira [43], Fgfr1 [44,45], Fgf8 [46], the Nodal target Eomeso-
dermin [47], and Snail1 [48], where cells fail to leave the
primitive streak. Exposure of Zebrafish embryos to Geminin
morpholinos similarly repressed Snail1a; mesendodermal
cells did not delaminate, while overexpression promoted
Snail1a production and endodermal differentiation [49],
suggesting that Geminin plays a central, critical role in this
cascade.
Sequelae of EMT inhibition
Failure of EMT had many sequelae, including the lack of
axis elongation after the failure of mesendoderm migration,
as in our EB model (Slawny and O’Shea, this volume). Ge-
minin appears to be required downstream of Nodal signal-
ing, since the PD axis was initially specified properly and
Nodal expression was not affected by Geminin dosage. Mi-
gration through the posterior streak was less affected, al-
though ectopic Snail1 and Brachyury positive cells were
present in the dorsal hindgut wall in Geminin mutant em-
bryos, and Geminin dose affected Snail1 expression in the
allantoic mesenchyme. The early migrating cardiac meso-
derm also appears to be unaffected by Geminin dose, sug-
gesting a cell type-, region- or stage-restricted role for
Geminin in lineage allocation at gastrulation.
Geminin mutant embryos exhibit body wall closure defects
after failure of morphogenetic movements and endoderm
differentiation, as previously reported in Zebrafish [49]. Lack
of normal anterior mesendoderm migration also resulted in
the failure of DE to replace PE, and persistent signaling in the
anterior region, identified by expanded Cer1 and Hesx1 ex-
pression, which likely have long-term effects on patterning of
the anterior central nervous system (CNS) [50]. Neural tube
closure defects were commonly observed in Geminin-targeted
embryos, and may result from notochord abnormalities as
FIG. 8. Geminin affects the differentiation of neurons from neural precursors. Localization of Sox3 (A–I) and TuJ1 ( J–R) in
control (A–C, J–L), Geminin shRNA (D–F, M–O), and Geminin overexpressing (G–I, P–R) embryos. E8.5 (A, D, G) and E9.5
(B–C, E–F, H–I, J–R) embryos were examined. (A, B, D, E, G, H, K, N, Q) are sagittal views with anterior to the left. (C, F, I, J,
M, P) are coronal/ventral views and (L, O, R) are coronal sections with anterior toward the top. H, heart; Hf, headfolds;
arrowhead (A–P), posterior neuropore. Scale bars = 200 mm (A–I, J–K, M–N, P–Q), 100 mm (L, O, R). Color images available
online at www.liebertonline.com/scd
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secreted factors from the notochord are essential for floor-
plate induction and the resulting elevation of the neural folds
[51]. Inhibition of BMP signaling is then required for the
formation of the dorsolateral hingepoints and midline ap-
proximation of the neural folds [52], suggesting that alter-
ations in Shh and/or BMP expression may play a role in the
genesis of the observed neural tube defects.
Geminin and the neural crest
Neural crest emigration has been considered a second
gastrulation event [53], and neural crest versus epidermal
identity is determined by BMP and Wnt signaling; interme-
diate levels of BMP signaling position the border [54–56]. A
second mesodermal Wnt signal [57] with BMP then activates
Msx1,2 gene expression [58], which induce expression of
Twist1, Snail1, and Slug [59] that then induce p21, and
downregulate E-Cadherin expression to promote EMT. In
fact, intermediate levels of Geminin overexpression (insuf-
ficient to induce neural markers) similarly expanded the
Twist-positive neural crest field [7,33]. In the current in-
vestigation, Geminin expression level strongly affected
Bmp4, Snail1, and Msx2 gene expression and Wnt signaling
by NCC.
In NCC, BMP-dependent Wnt signaling has been shown
to control the transition from G1 to S by modulating intra-
cellular levels of cyclins [60]. Premigratory NCC are arrested
in G1 and enter S on delamination; repression of the G1 to S
transition inhibits the EMT process [61]. The unique ability of
Geminin to both modulate cell cycle, while negatively
modulating E-cadherin, BMP, and Fgf gene expression and
to positively regulate Wnt signaling place it in a unique
position to control EMT and thereby tissue organization
during development. The observation that decreased Gemi-
nin levels inhibit EMT and maintain neural crest stem cells,
while overexpression promotes their migration, are similar to
results in subventricular zone neural stem cells where dele-
tion of Geminin promoted self-renewal and expanded the
progenitor population while overexpression promoted mi-
gration and differentiation [62], suggesting that similar
mechanisms may maintain these stem cell niches. The ob-
servation that Geminin controls EMT may also inform our
understanding of metastasis, as Geminin is overexpressed in
a number of tumors where it is negatively correlated with
outcome [63].
Geminin dose affects Bmp4 and Wnt Signaling
This is the first identification of the strong correlation
between Geminin and Wnt signaling, which is required in
the epiblast to position and maintain the primitive streak
[64]. Overexpression of Wnt8c [65], interference with b-
catenin degradation [66], or deletion of negative regulators
[67,68] expand or duplicate the primitive streak, as ob-
served with Geminin knockdown. Geminin and Wnts may
act reciprocally since the Geminin promoter contains TCF-
binding sites [69], Geminin may control Wnt target gene
expression via Snail1 [70], or Geminin may bind a Groucho
factor to modulate Wnt signaling (Slawny and O’Shea, this
volume).
Given the strong negative correlation between Geminin
and Bmp4 expression, the requirement for BMP signaling in
the formation of the node and primitive streak, and specifi-
cation of mesoderm [71,72], interference with BMP signaling
may also play a role in the gastrulation block observed in
Geminin mutant embryos. The effect may be direct as sug-
gested by data from amphibian [7] and chick embryos [35],
or Geminin may interact with additional pathway members,
for example, Smad proteins in the nucleus.
Neural differentiation
Geminin has been suggested to mark the acquisition by
the ectoderm of neural competence [73]. The striking lack of
Geminin in the epidermal ectoderm suggests that Geminin
may function in the ectoderm like other preneural genes,
such as Sox3 and Zic2 that are required for the induction of
neural tissue by BMP inhibition, thereby positioning the
neural-epidermal ectodermal border [54,73], consistent with
observations that overexpression increases and reductions in
Geminin reduce the size of the neural plate in Xenopus [7],
Zebrafish [49], and Drosophila [10] embryos. Geminin may
then maintain proliferation in the neural ectoderm and pre-
vent premature expression of genes involved in fate-
restriction [34,35,74]. These effects are both context- and
dose-dependent. In the Xenopus embryo, high levels of
Geminin are required to induce ectopic expression of neu-
ronal markers, while low levels of suppression did not affect
neuronal fate acquisition, but promoted premature neuronal
differentiation [8,74]. Our results reflect a similar dosage ef-
fect; with knockdown producing premature differentiation
of midbrain neurons, consistent with the strong negative
correlation between Geminin and Neurog1. High levels of
expression also resulted in a loss of Sox gene expression and
dysregulated expression of neuronal markers, and it is pos-
sible that Sox3 expression was accelerated rather than abro-
gated. Recent reports indicate that deletion of Geminin in
nestin + cells of the nervous system had little effect on the
number or differentiation of precursors in one case [75],
while deletion expanded progenitors in the subventricular
zone and overexpression promoted migration and prema-
ture differentiation [62] in another. These results, and in vitro
studies in embryonic stem cells (Slawny and O’Shea, this
volume) emphasize the context- and dose-dependent effects
of Geminin and suggest that it may play very different roles
in lineage-committed precursors versus cells with multi-
lineage differentiation potential such as the neural crest and
primitive streak.
Ultimately, Geminin’s effects are likely determined by the
availability of protein partners in the nucleus, such as the
Brahma-related gene 1, Brg1, which regulates both proneural
bHLH [76] and Sox gene expression [35]. Brg1 activates Wnt
reporters [77], interacts with nuclear b-catenin to control
gene expression [78,79], and can be recruited to target gene
promoters by Groucho proteins [78]. The striking correlation
between Geminin expression, Wnt reporter activity, and tar-
get gene expression suggests that in the mouse embryo,
Geminin may regulate Wnt signaling via Brg1 or yet un-
identified nuclear factors. Geminin is expressed in multiple
stem cell populations—embryonic stem cells, neural stem
cells, the primitive streak, and gut stem cells, and over-
expression in tumors is strongly negatively correlated with
survival. Additional study of Geminin’s role in tissue-type
transitions involved in the morphogenesis of other organs
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will likely require reconstruction in tissue restricted or in-
ducible systems.
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